{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:05Z","timestamp":1787010065591,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/jcp.0b013e3182a11622","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T06:55:38Z","timestamp":1376722538000},"page":"717-719","source":"Crossref","is-referenced-by-count":6,"title":["Bupropion-Related Visual Hallucinations in a Veteran With Posttraumatic Stress Disorder and Multiple Sclerosis"],"prefix":"10.1097","volume":"33","author":[{"given":"Gotaro","family":"Kojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiko","family":"Karino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misuzu","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Epure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Tsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210128","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity.","volume":"56","author":"Ascher","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"R2-25-20210128","first-page":"53","article-title":"Organic mental disorders associated with bupropion in three patients.","volume":"53","author":"Ames","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"R3-25-20210128","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1176\/ajp.142.12.1459","article-title":"Psychoses associated with bupropion treatment.","volume":"142","author":"Golden","year":"1985","journal-title":"Am J Psychiatry"},{"key":"R4-25-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-2002-36393","article-title":"Acute psychosis after administration of bupropion hydrochloride (Zyban).","volume":"35","author":"Neumann","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"R5-25-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3122\/jabfm.2008.03.070236","article-title":"Acute psychosis after bupropion treatment in a healthy 28-year-old woman.","volume":"21","author":"Bailey","year":"2008","journal-title":"J Am Board Fam Med"},{"key":"R6-25-20210128","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/JCP.0b013e31814fb98e","article-title":"Perceptual disturbances associated with low-dose bupropion sustained-release treatment.","volume":"27","author":"Liu","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R7-25-20210128","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1176\/jnp.23.2.jnpe53","article-title":"Gustatory and olfactory hallucinations under therapeutic dosing of bupropion.","volume":"23","author":"Kroemer","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R8-25-20210128","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4088\/JCP.v67n1122e","article-title":"Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients.","volume":"67","author":"Charuvastra","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R9-25-20210128","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0033-3182(94)71797-7","article-title":"Bupropion for the treatment of fatigue associated with multiple sclerosis.","volume":"35","author":"Duffy","year":"1994","journal-title":"Psychosomatics"},{"key":"R10-25-20210128","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.clinthera.2010.10.012","article-title":"Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis.","volume":"32","author":"Siniscalchi","year":"2010","journal-title":"Clin Ther"},{"key":"R11-25-20210128","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1176\/ajp.156.12.2017-a","article-title":"Bupropion-induced psychosis.","volume":"156","author":"Howard","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R12-25-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archpsyc.1988.01800260055007","article-title":"Bupropion in depression. II. The role of metabolites in clinical outcome.","volume":"45","author":"Golden","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R13-25-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7205\/MILMED.172.3.273","article-title":"Psychotic symptoms in combat-related post-traumatic stress disorder.","volume":"172","author":"Kastelan","year":"2007","journal-title":"Mil Med"},{"key":"R14-25-20210128","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0006-3223(98)00301-1","article-title":"Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder.","volume":"45","author":"Hamner","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R15-25-20210128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-199810000-00005","article-title":"Bupropion treatment in veterans with posttraumatic stress disorder: an open study.","volume":"18","author":"Canive","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R16-25-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-200102000-00017","article-title":"A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder.","volume":"21","author":"Hertzberg","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R17-25-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/YCO.0b013e3280eb10d7","article-title":"The neuropsychiatry of multiple sclerosis: a review of recent developments.","volume":"20","author":"Ghaffar","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"R18-25-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/09540261003589612","article-title":"Psychotic features associated with multiple sclerosis.","volume":"22","author":"Kosmidis","year":"2010","journal-title":"Int Rev Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182a11622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T15:59:45Z","timestamp":1715875185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201310000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182a11622","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}